TYMP
TYMP (thymidine phosphorylase, also known as MNGIE or ECGF1) is an enzyme that catalyses the reversible phosphorolysis of thymidine. It also acts as an angiogenic factor that stimulates the growth of endothelial cells. Browse Assay Genie's current range of TYMP research reagents below, or read on for the biology behind the target.
TYMP catalyses the reversible phosphorolysis of thymidine. The molecules produced by this reaction are then used as carbon and energy sources, or in the rescue of pyrimidine bases for nucleotide synthesis. This places the TYMP protein within pyrimidine nucleoside metabolism, where it links nucleoside breakdown to salvage pathways. It belongs to the thymidine/pyrimidine-nucleoside phosphorylase family and is assigned EC 2.4.2.4.
Beyond its enzymatic role, the TYMP gene encodes an angiogenic factor. According to the NCBI Gene summary, it promotes angiogenesis in vivo and stimulates the in vitro growth of a variety of endothelial cells. Its target cell specificity is highly restricted, and it acts only on endothelial cells. This dual character, as a metabolic enzyme and as a growth-promoting factor, makes TYMP a useful subject for studies that connect nucleotide metabolism with vascular biology. Multiple alternatively spliced transcript variants have been identified. The human protein has mouse and rat orthologs, both named Tymp, which allows comparative work in rodent systems.
The gene's older name, endothelial cell growth factor 1 (platelet-derived), gives the symbol ECGF1 and reflects its discovery as an endothelial mitogen. HGNC places it in the group of minor histocompatibility antigens. Mutations in TYMP have been associated with mitochondrial neurogastrointestinal encephalomyopathy, which accounts for the alias MNGIE. Researchers studying this disorder, angiogenesis or pyrimidine salvage often work with TYMP, whether they use an antibody, an ELISA kit or recombinant protein.
TYMP promotes angiogenesis in vivo and stimulates the growth of endothelial cells, with a highly restricted target cell specificity.
TYMP phosphorolyses thymidine reversibly, and the products feed carbon and energy use or the rescue of pyrimidine bases for nucleotide synthesis.
Mutations in the TYMP gene are associated with mitochondrial neurogastrointestinal encephalomyopathy, making it central to MNGIE research.
As an endothelial-specific growth stimulator originally named endothelial cell growth factor 1, TYMP is relevant to studies of endothelial proliferation.
TYMP catalyses the reversible phosphorolysis of thymidine. The products are used as carbon and energy sources or to rescue pyrimidine bases for nucleotide synthesis. It also functions as an angiogenic factor that stimulates the growth of endothelial cells, acting only on that cell type.
ECGF1 comes from the previous name, endothelial cell growth factor 1 (platelet-derived), reflecting its action on endothelial cells. MNGIE refers to mitochondrial neurogastrointestinal encephalomyopathy, a condition associated with mutations in this gene. Multiple alternatively spliced transcript variants have also been identified.
Yes. Mouse and rat each have an ortholog named Tymp, so the gene can be studied in rodent models. As with any target, check the datasheet of any product for its validated reactivity before choosing a reagent for a given species.
Pyrimidine metabolism enzymes, angiogenesis factors and mitochondrial disease markers related to TYMP.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P19971; product specifications from Assay Genie datasheets.